[Tardive dystonia].
Fujiwara
Yutaka
Y
Takaoka Hospital.
Otani
Kyohei
K
D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001905:Botulinum Toxins / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists; D004421:Dystonia / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D012015:Reference Standards; D012737:Sex Factors
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D001905:Botulinum Toxins; D004298:Dopamine